SELLING INTENT
Abbott Laboratories's Robert J. Alpern (Retired Director) Filed Intent to Sell 7,587 Shares (~$0.6M)
Abbott Laboratories (ABT) had 1 Form 144 pre-sale notice filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
5/16/2026 · 0 views